Hemal Somaiya, Chief Strategy Officer, PharmaForceIQ

Articles by Hemal Somaiya, Chief Strategy Officer, PharmaForceIQ

Strategic advantage: Optichannel engagement drives ROI across the product lifecycle

ByHemal Somaiya, Chief Strategy Officer, PharmaForceIQ

August 5th 2025

Latest Updated Articles

Trending on PharmExec

Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure

President Trump Set to Nominate Heidi Overton as FDA Commissioner

When Drug Pricing Becomes Trade Policy

From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle

Pharmaceutical Executive Daily: President Trump to Nominate Heidi Overton as FDA Commissioner